Welgene Biotech Co.,Ltd. (TPEX:6661)
Taiwan · Delayed Price · Currency is TWD 16.15
+0.60 (3.86%)
Nov 6, 2026, 11:09 AM CST
Welgene Biotech Market Cap
Welgene Biotech has a market cap or net worth of 376.36 million as of November 6, 2026. It is the 40,558th most valuable company in the world and the 2,316th biggest in Taiwan. Its market cap has decreased by 13.40% in one year.
Market Cap
376.36M
Enterprise Value
460.72M
Revenue
398.92M
Global Rank
Country Rank
#2,316 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 23, 2017, Welgene Biotech's market cap has decreased from 575.10M to 376.36M, a decrease of -34.56%. That is a compound annual growth rate of -4.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 376.36M | -13.17% |
| Dec 31, 2025 | 433.46M | -21.85% |
| Dec 30, 2024 | 554.64M | 6.49% |
| Dec 29, 2023 | 520.85M | 0.68% |
| Dec 30, 2022 | 517.35M | -9.20% |
| Dec 30, 2021 | 569.79M | -23.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 2.29B |
| DIVA Laboratories | 1.77B |
| Puriblood Medical | 1.01B |
| Genetics Generation Advancement | 935.66M |
| Kim Forest Enterprise | 769.90M |
| Sofiva Genomics | 708.26M |
| TFBS Bioscience | 614.93M |
| Pharmigene | 406.24M |